Last reviewed · How we verify

NCT03865004

Combination Trial of Intravenous Paracetamol - Morphine for Treating Acute Renal Colic in Emergency Setting: An Optimum Treatment

Completed Phase 4 Last updated 6 March 2019
What this trial tests

Phase 4 trial testing Paracetamol+Morphine in Renal Colic in 136 participants. Completed in 17 October 2018.

Timeline
17 October 2015
Primary endpoint
17 October 2016
17 October 2018

Quick facts

Lead sponsorAkdeniz University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment136
Start date17 October 2015
Primary completion17 October 2016
Estimated completion17 October 2018

Drugs / interventions tested

Conditions studied

Sponsor

Akdeniz University

Who can join

Adults 18 to 55, any sex, with Renal Colic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, placebo-controlled trial evaluated the analgesic efficacy and safety of intravenous morphine-paracetamol combination and morphine-dexketoprofen combination morphine for the optimum treatment of renal colic. Combination of IV morphine and paracetamol is as effective and rapid as combination of IV Morphine and IV dexketoprophen for optimum treating of renal colic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Renal Colic

Currently open trials in the same condition.

Other Akdeniz University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03865004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing